Non–Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves | Circulation

The estimated prevalence of mitral or aortic valvular heart disease is ≈2.5% in the general population of Western countries, and is expected to rise with population aging. A substantial proportion of